Vergleich

Nutlin-3 Europäischer Partner

ArtNr S1061-1000
Hersteller Selleckchem
CAS-Nr. 890090-75-2
Menge 1 g
Kategorie
Typ Inhibitors
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 890090-75-2'
Similar products Nutlin-3
Lieferbar
Administration
Orally, twice a day
Animal Models
Athymic female nude mice (Nu/Nu-nuBR) injected subcutaneously with SJSA-1 cells
Cell lines
HCT116, RKO, SJSA-1, SW480, and MDA-MB-435
Chemical Name
4-(4, 5-bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4, 5-dihydro-1H-imidazole-1-carbonyl)piperazin-2-one
Concentrations
Dissolved in DMSO, final concentrations ca. 30 uM
Description
Nutlin-3 is a potent and selective Mdm2 antagonist with IC50 of 90 nM.
Dosages
200 mg/kg
Formulation
Formulated in 2% Klucel, 0.5% Tween 80
IC50
90 nM [1], 90 nM [1], 90 nM [1], 90 nM [1], 90 nM [1], 90 nM [1]
In vitro
Nutlin-3 potently inhibits the MDM2-p53 interaction, leading to the activation of the p53 pathway. Nutlin-3 treatment induces the expression of MDM2 and p21, and displays potent antiproliferative activity with IC50 of ca.1.5 uM, only in cells with wild-type p53 such as HCT116, RKO and SJSA-1, but not in the mutant p53 cell lines SW480 and MDA-MB-435. In SJSA-1 cells, Nutlin-3 treatment at 10 uM for 48 hours significantly induces caspase-dependent cell apoptosis by ca.45%. Although Nutlin-3 also inhibits the growth and viability of human skin (1043SK) and mouse embryo (NIH/3T3) with IC50 of 2.2 uM and 1.3 uM, respectively, cells remain viable 1 week post-treatment even at 10 uM of Nutlin-3, in contrast with the SJSA-1 cells with viability lost at 3 uM of Nutlin-3 treatment. [1] Nutlin-3 does not induce the phosphorylation of p53 on key serine residues and reveals no difference in their sequence-specific DNA binding and ability to transactivate p53 target genes compared with phosphorylated p53 induced by the genotoxic drugs doxorubicin and etoposide, demonstrating that phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. [2] Although binding less efficiently to MDMX than to MDM2, Nutlin-3 can block the MDMX–p53 interaction and induce the p53 pathway in retinoblastoma cells (Weri1) with IC50 of 0.7 uM. [3] Nutlin-3 at 30 uM also disrupts endogenous p73-HDM2 interaction and enhances the stability and proapoptotic activities of p73, leading to the dose-dependent cell growth inhibition and apoptosis induction in cells without wild-type p53. [4]
In vivo
Oral administration of Nutlin-3 at 200 mg/kg twice daily for 3 weeks significantly inhibits the tumor growth of SJAS-1 xenografts by 90%, comparable with the effect of doxorubicin treatment with 81% inhibition of tumor growth. [1]
Incubation Time
8, 24, and 48 hours
Kinase Assay
Biacore study, Competition assay is performed on a Biacore S51. A Series S Sensor chip CM5 is, utilized for the immobilization of a PentaHis antibody for capture of the His-tagged p53. The level of capture is ca.200 response units (1 response unit corresponds to 1 pg of protein per mm2). The concentration of MDM2 protein is kept constant at 300 nM. Nutlin-3 is dissolved in DMSO at 10 mM and further diluted to make a concentration series of Nutlin-3 in each MDM2 test sample. The assay is run at 25 C in running buffer (10 mM Hepes, 0.15 M NaCl, 2% DMSO). MDM2-p53 binding in the presence of Nutlin-3 is calculated as a percentage of binding in the absence of Nutlin-3 and IC50 is calculated.
Method
Cells are exposed to various concentrations of Nutlin-3 for 8, 24 and 48 hours. The transcriptional levels of p21 and MDM2 genes are analyzed by real-time PCR, and protein levels by western blotting. Cell viability is measured by the MTT assay. Cell apoptosis is determined by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling (TUNEL) staining with flow cytometry and fluorescence microscopy.
Molecular Weight (MW)
581, 5
Picture ChemicalStructure Description
Nutlin-3 Chemical Structure
Picture Description 1
, , Nutlin-3purchased from Selleck, Figure 1: (a): 21DIV rat cortical neurons treated with the MDM2 inhibitor nutlin-3 (N3) for 24h (DMSO veh). Neuronal viability was measured via MAP2-based ELISA. (d): Prior to 24h treatment with 10uM N3 (MDM2 inhibitor) or 20uM SJ (MDMX inhibitor), neurons were pre-treated for 30min with the pan-caspase inhibitor Q-VD-OPh (50uM) or the calpain protease inhibitor MDL-28170 (20uM). Viability measured via MAP2-based ELISA. Inhibition of caspases prevented N3-induced neuronal damage, and inhibition of calpains prevented N3- and SJ-induced neuronal damage (*= p0.05, Students t-test, n=3).
Picture Description 2
Data from [Cell Death Dis , 2011, 2, e243], Nutlin-3purchased from Selleck, Caspase 3/7 activation in UKF-NB-3 or UKF-NB-3rNutlin10 M cells treated nutlin-3 (10 M), VCR (10 ng/ml), DOX (20 ng/ml), or CDDP (1000 ng/ml).
Solubility (25C)
DMSO 116 mg/mL, Water <1 mg/mL, Ethanol 116 mg/mL
Storage
2 years -20CPowder, 2 weeks4Cin DMSO, 2 months-80Cin DMSO

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 1 g
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen